Global Next Generation Cancer Diagnostics Market Size Study, By Technology (NGS, LOAC & RT-PCR), By Application (CTC, Biomarker, Proteomic), By Cancer Type (Lung, Breast), By Function Companion Diagnostics) and Regional Forecasts, 2017-2025
- BIZ2843825
- 180 Pages
- December 2017
- Healthcare
Global Next Generation Cancer Diagnostics Market is valued approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more précised prognosis of various types of cancer, the next generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the global infertility treatment market are given below:
Technology:
? NGS-based cancer diagnostics
? qPCR & Multiplexing
? Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
? Protein microarrays-based cancer diagnostics
? DNA microarrays-based cancer diagnostics
Type:
? Lung Cancer
? Breast Cancer
? Colorectal Cancer
? Cervical Cancer
? Others
Applications:
? Biomarker Development
? CTC Analysis
? Proteomic Analysis
? Epigenetic Analysis
? Genetic Analysis
Functions:
? Therapeutic Monitoring
? Companion Diagnostics
? Prognostic Diagnostics
? Cancer Screening
? Risk Analysis
Regions:
? North America
o U.S.
o Canada
? Europe
o UK
o Germany
o France
? Asia Pacific
o China
o India
o Japan
? Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year - 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are; Novartis AG, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott , GE Healthcare , Thermo Fisher Scientific, Inc.
Target Audience of the Next Generation Cancer Diagnostics Market Study
? Key Consulting Companies & Advisors
? Large, medium-sized, and small enterprises
? Venture capitalists
? Value-Added Resellers (VARs)
? Third-party knowledge providers
? Investment bankers
? Investors
Please note, that owing to the criticality of the Next Generation Cancer Diagnostic industry and rapidly changing market attributes, we are the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in o
1.1. Research Process
1.1.1. Data Mining
1.1.2. Analysis
1.1.3. Market Estimation
1.1.4. Validation
1.1.5. Publishing
1.2. Research Assumption
Chapter 2. Global Next Generation Cancer Diagnostics Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter 4. Global Next Generation Cancer Diagnostics Industry Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Next Generation Cancer Diagnostics Market by Technology
5.1. Market Snapshot
5.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
5.2.1. NGS-based cancer diagnostics
5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2. qPCR & Multiplexing
5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3. Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4. Protein microarrays-based cancer diagnostics
5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5. DNA microarrays-based cancer diagnostics
5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
5.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 6. Global Next Generation Cancer Diagnostics Market by Type
6.1. Market Snapshot
6.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
6.2.1. Lung Cancer
6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2. Breast Cancer
6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3. Colorectal Cancer
6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4. Cervical Cancer
6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.5. Others
6.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
6.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 7. Global Next Generation Cancer Diagnostics Market by Application
7.1. Market Snapshot
7.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
7.2.1. Biomarker Development
7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2. CTC Analysis
7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.3. Proteomic Analysis
7.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.4. Epigenetic Analysis
7.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.5. Genetic Analysis
7.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
7.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 8. Global Next Generation Cancer Diagnostics Market by Function
8.1. Market Snapshot
8.2. Next Generation Cancer Diagnostics Market, Sub Segment Analysis
8.2.1. Therapeutic Monitoring
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.2. Companion Diagnostics
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.3. Prognostic Diagnostics
8.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.4. Cancer Screening
8.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.5. Risk Analysis
8.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
8.2.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 9. Global Next Generation Cancer Diagnostics Market, Regional Analysis
9.1. Next Generation Cancer Diagnostics Market, Regional Market Snapshot (2015-2025)
9.2. North America Next Generation Cancer Diagnostics Market Snapshot
9.2.1. U.S. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2. Canada Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3. Europe Next Generation Cancer Diagnostics Market Snapshot
9.3.1. U.K. Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2. Germany Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3. France Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4. Rest of Europe Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4. Asia Next Generation Cancer Diagnostics Market Snapshot
9.4.1. China Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2. India Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3. Japan Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4. Rest of Asia Pacific Next Generation Cancer Diagnostics Market Size Estimates & Forecasts, 2015-2025 (USD Billion/Million)
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.4.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5. Rest of The World Next Generation Cancer Diagnostics Market Snapshot
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
9.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion/Million)
Chapter 10. Competitive Intelligence
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Agilent Technologies (Dako)
10.3.3. Almac Group
10.3.4. Cepheid
10.3.5. F. Hoffmann-La Roche Ltd
10.3.6. GE Healthcare
10.3.7. Illumina, Inc.
10.3.8. Janssen Global Services, LLC
10.3.9. Koninklijke Philips N.V.
10.3.10. Novartis AG
10.3.11. Perkin Elmer, Inc.
10.3.12. Qiagen
10.3.13. Thermo Fisher Scientific, Inc.
//
Please note that currency denotation (USD Billion/Million) is provided on the basis of preliminary study, this may change in the final deliverables. Further, shipment values are subject to data availability.
//
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET
TABLE 3. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION/BILLION)
TABLE 7. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD MILLION/BILLION)
TABLE 8. GLOBAL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD MILLION/BILLION)
TABLE 9. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 1, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 10. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 11. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 2, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 12. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 13. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 3, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 14. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 15. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 4, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 16. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 17. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 5, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 18. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 19. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 6, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 20. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 21. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 7, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 22. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 23. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 8, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 24. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 25. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 9, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 26. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 27. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 10, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 28. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 29. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY SEGMENT 11, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 30. NEXT GENERATION CANCER DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 31. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 32. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 33. U.S. NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 34. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 35. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 36. CANADA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 37. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 38. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 39. UK NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 40. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 41. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 42. GERMANY NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 43. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 44. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 45. ROE NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 46. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 47. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 48. CHINA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 49. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 50. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 51. INDIA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 52. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 53. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 54. JAPAN NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 55. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 56. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 57. ROAPAC NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 E 2015-2025 (USD MILLION/BILLION)
TABLE 58. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 59. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 60. BRAZIL NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 61. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 62. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT1 2015-2025 (USD MILLION/BILLION)
TABLE 63. MEXICO NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 64. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 65. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 66. ROLA NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
TABLE 67. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION/BILLION)
TABLE 68. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 1 2015-2025 (USD MILLION/BILLION)
TABLE 69. ROW NEXT GENERATION CANCER DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2 2015-2025 (USD MILLION/BILLION)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
